Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1001/jamaoncol.2019.0528
10.1001/jamaoncol.2019.0528 · External reference
Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
10.1186/s13045-021-01089-z · 2021 · External reference
10.1158/1078-0432.ccr-21-2404
10.1158/1078-0432.ccr-21-2404 · External reference
10.1038/s41591-022-02115-4
10.1038/s41591-022-02115-4 · External reference
Measurable residual disease (MRD)-testing in haematological and solid cancers
10.1038/s41375-024-02252-4 · 2024 · External reference
10.1038/s41591-025-03579-w
10.1038/s41591-025-03579-w · External reference
Unresolved reference
External reference
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases
10.1200/po.21.00101 · 2021 · External reference
Personalizing adjuvant therapy for patients with colorectal cancer
10.1038/s41571-023-00834-2 · 2024 · External reference
Circulating Tumor DNA as Biomarkers for Cancer Detection
10.1016/j.gpb.2016.12.004 · 2017 · External reference
Unresolved reference
External reference
10.1056/nejmoa2200075
10.1056/nejmoa2200075 · External reference
Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study
10.1200/jco.2024.42.3_suppl.9 · 2024 · External reference
10.1038/s41586-023-06225-y
10.1038/s41586-023-06225-y · External reference
Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy
10.3390/cancers13092231 · 2021 · External reference
10.1200/jco.2015.63.4238
10.1200/jco.2015.63.4238 · External reference
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
10.1016/s0140-6736(07)61866-2 · 2007 · External reference
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
10.1038/s41591-025-04030-w · 2025 · External reference
Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer
10.1056/nejme2204625 · 2022 · External reference
1152-60 feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: The pilot phase of a randomised controlled trial. Côlon rectum
2012 · External reference
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
10.1126/scitranslmed.aaf6219 · 2016 · External reference
10.1136/gutjnl-2017-315852
10.1136/gutjnl-2017-315852 · External reference
Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases
10.1016/j.jamcollsurg.2021.02.011 · 2021 · External reference
Circulating Tumor DNA Testing in Curatively Resected Colorectal Cancer and Salvage Resection
10.1001/jamanetworkopen.2024.52661 · 2024 · External reference
IMPROVE-IT2: implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer - intervention trial 2. Study protocol
10.1080/0284186x.2019.1711170 · 2020 · External reference
Patient-reported outcomes from the BESPOKE CRC study
10.1200/jco.2024.42.3_suppl.54 · 2024 · External reference
“A lot can happen in that time”: understanding patients’ perspectives on reduced surveillance frequency and the potential for circulating tumor DNA blood tests after colorectal cancer treatment
2025 · External reference
